Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)
CUSIP: 87184Q107
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 27,995,500
- Total 13F shares
- 7,667,574
- Share change
- +7,667,574
- Total reported value
- $119,948,000
- Price per share
- $18.15
- Number of holders
- 11
- Value change
- +$119,948,000
- Number of buys
- 11
Quarterly Holders Quick Answers
What is CUSIP 87184Q107?
CUSIP 87184Q107 identifies SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q3 2016
Recent filing periods for CUSIP 87184Q107:
Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q2 2016
As of 30 Jun 2016,
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,667,574 shares.
The largest 10 holders included
FMR LLC, DEERFIELD MANAGEMENT CO, Redmile Group, LLC, Aisling Capital LLC, BAKER BROS. ADVISORS LP, Foresite Capital Management III, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Alyeska Investment Group, L.P., Casdin Capital, LLC, and Weiss Multi-Strategy Advisers LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2023 Across Filers
Q1 2023 holders
1
Q2 2016 holders
11
Holder diff
10
| Investor | Q1 2023 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.